Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Climbed Today

TheMotleyFool

0 0

Shares of Moderna (NASDAQ: MRNA) rose 4.9% on Monday, after the biotechnology company said it began a study of an experimental COVID-19 vaccine with less restrictive storage requirements.

Moderna dosed the first participants in its phase 1 trial of mRNA-1283, the biotech's refrigerator-stable COVID-19 vaccine candidate. Should it prove both safe and effective, the new vaccine would be easier to transfer, store, and administer, according to CEO Stephane Bancel. That could make it particularly compelling for distribution in markets with less advanced healthcare infrastructure.

Investors bid up Moderna's stock price on Monday. Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share